/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

US Stock Details

Get in-depth insights on US stocks, including fundamentals, financials, shareholding, peer comparison, and performance. Track key metrics, price trends, and market sentiment for informed decisions. Stay ahead with expert analysis and data-driven strategies at Motilal Oswal.

style
pb-0

HeartSciences Inc

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0
$2.5207 0.0119(1.19%) HSCS at 04 Dec 2025 04:34 PM Medical Devices
Lowest Today 2.47
Highest Today 2.58
Today’s Open 2.52
Prev. Close 2.52
52 Week High 6.47
52 Week Low 2.01
Day’s Range: Low 2.47 High 2.58
52-Week Range: Low 2.01 High 6.47
1 day return -
1 Week return -7.83
1 month return -12.72
3 month return -25.82
6 month return -37.93
1 year return -27.98
3 year return -98.19
5 year return -
10 year return -

Institutional Holdings

Citadel Advisors Llc 0.74

Geode Capital Management, LLC 0.46

Advisory Services Network, LLC 0.39

Fidelity Extended Market Index 0.23

Fidelity Total Market Index 0.09

Spartan Extended Market Index Pool F 0.09

NT Ext Equity Mkt Idx Fd - NL 0.07

Fidelity Series Total Market Index 0.05

Vanguard Institutional Extnd Mkt Idx Tr 0.05

NT Ext Equity Mkt Idx Fd - DC - NL - T2 0.05

Northern Trust Extended Eq Market Idx 0.04

NT Ext Equity Mkt Idx Fd - L 0.04

Tower Research Capital LLC 0.03

Federation des caisses Desjardins du Quebec 0.02

NT Ext Eq Mkt Indx Fd DC Lending Tier 5 0.01

NT Ext Eq Mkt Indx Fd DC Lend T3 0.01

Spartan Total Market Index Pool G 0.01

Bank of America Corp 0.00

Advisor Group Holdings, Inc. 0.00

UBS Group AG 0.00

Market Status

Strong Buy: 1

Buy: 1

Hold: 0

Sell: 0

Strong Sell: 0

Fundamentals

Market Cap 9.49 M

PB Ratio 2.4743

PE Ratio 0.0

Enterprise Value 6.93 M

Total Assets 4.22 M

Volume 4013

Company Financials

Annual Revenue FY25:4350 0.0M, FY24:18600 0.0M, FY23:5150 0.0M, FY22:14373 0.0M, FY21:25604 0.0M

Annual Profit FY25:2470 0.0M, FY24:12519 0.0M, FY23:2354 0.0M, FY22:6483 0.0M, FY21:14939 0.0M

Annual Net worth FY25:-8765229 -8.8M, FY24:-6605208 -6.6M, FY23:-490854290 -490.9M, FY22:-4578060 -4.6M, FY21:-2581173 -2.6M

Quarterly Revenue Q3/2025:1900000 1.9M, Q2/2025:4350 0.0M, Q1/2025:0 0.0M, Q4/2024:0 0.0M, Q3/2024:0 0.0M

Quarterly Profit Q3/2025:1140000 1.1M, Q2/2025:2470 0.0M, Q1/2025:67728 0.1M, Q4/2024:0 0.0M, Q3/2024:-33318 -0.0M

Quarterly Net worth Q3/2025:-2054994 -2.1M, Q2/2025:-2094330 -2.1M, Q1/2025:-2536292000 -2536.3M, Q4/2024:-2082918 -2.1M, Q3/2024:-2051689 -2.1M

Fund house & investment objective

Company Information HeartSciences Inc., a medical technology company, focuses on applying AI-based technology to an ECG to expand and improve clinical usefulness. It develops artificial intelligence-enhanced electrocardiography (AI-ECG) solutions, an algorithm to detect impaired cardiac relaxation or cardiac dysfunction caused by heart disease and/or age-related cardiac dysfunction; MyoVista wavECG device, a resting 12-lead ECG that provides diagnostic information related to cardiac dysfunction, as well as conventional ECG information in the same test; and MyoVista Insights, a cloud-based platform to host AI-ECG algorithms on an ECG hardware agnostic basis. The company was formerly known as Heart Test Laboratories, Inc. and changed its name to HeartSciences Inc. in October 2024. HeartSciences Inc. was incorporated in 2007 and is headquartered in Southlake, Texas.

Organisation Medical Devices

Employees 15

Industry Medical Devices

CEO Mr. Andrew Simpson

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow